DENTSPLY SIRONA Inc. (XRAY)

NASDAQ: XRAY · Real-Time Price · USD
13.85
+0.80 (6.13%)
At close: Aug 13, 2025, 4:00 PM
13.85
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:36 PM EDT
6.13%
Market Cap 2.76B
Revenue (ttm) 3.67B
Net Income (ttm) -949.00M
Shares Out 199.48M
EPS (ttm) -4.76
PE Ratio n/a
Forward PE 7.13
Dividend $0.64 (4.63%)
Ex-Dividend Date Sep 26, 2025
Volume 5,062,660
Open 13.09
Previous Close 13.05
Day's Range 13.01 - 14.00
52-Week Range 12.16 - 27.48
Beta 0.95
Analysts Hold
Price Target 19.10 (+38.06%)
Earnings Date Aug 7, 2025

About XRAY

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as w... [Read more]

Sector Healthcare
IPO Date Aug 12, 1987
Employees 14,000
Stock Exchange NASDAQ
Ticker Symbol XRAY
Full Company Profile

Financial Performance

In 2024, DENTSPLY SIRONA's revenue was $3.79 billion, a decrease of -4.34% compared to the previous year's $3.97 billion. Losses were -$910.00 million, 589.4% more than in 2023.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for XRAY stock is "Hold." The 12-month stock price target is $19.1, which is an increase of 38.06% from the latest price.

Price Target
$19.1
(38.06% upside)
Analyst Consensus: Hold
Stock Forecasts

News

DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Daniel T. Scavilla - President, CEO & Direc...

5 days ago - Seeking Alpha

Dentsply Sirona Reports Second Quarter 2025 Results

CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2025.

6 days ago - GlobeNewsWire

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook

23 days ago - GlobeNewsWire

Dental 3D Printing Market Forecast Study 2025, with Leading Dental Companies and Innovators BEGO, Dentsply Sirona, WhipMix, Straumann, Ivoclar, Formlabs, SprintRay, Asiga, and Shining3D

Explore the latest dental 3D printing market trends. Discover insights into dental segment growth, technological adoption, and 2024 revenue data of $5.2B. The market is poised to nearly double by 2033...

4 weeks ago - GlobeNewsWire

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and l...

4 weeks ago - GlobeNewsWire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company")...

2 months ago - Accesswire

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company")...

2 months ago - Accesswire

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company")...

2 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company")...

2 months ago - Accesswire

INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY

PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Dentsply Sirona Inc. (NASDAQ:XRAY) ("Dentspl...

2 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

2 months ago - Accesswire

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million a...

2 months ago - GlobeNewsWire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

2 months ago - Accesswire

Buying Dentsply Sirona

I'm changing my tune on XRAY and buying at current levels due to its cheap valuation and attractive risk premium over Treasuries. Despite sluggish recent financials, the balance sheet is solid with am...

2 months ago - Seeking Alpha

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

2 months ago - Accesswire

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

CHARLOTTE, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Matthew E. Garth has been appointed Executive Vice Presi...

2 months ago - GlobeNewsWire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

2 months ago - Accesswire

Dentsply Sirona Declares Quarterly Cash Dividend

CHARLOTTE, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $...

2 months ago - GlobeNewsWire

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

2 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

2 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

2 months ago - Accesswire

Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference

CHARLOTTE, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2025 Stifel Jaws & P...

3 months ago - GlobeNewsWire

Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Shareholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

3 months ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Shareholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / May 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...

3 months ago - Accesswire

Dentsply Sirona Stock Is Rallying The Most Since 2019 on Thursday – What's Driving It?

Dentsply Sirona Inc. XRAY stock surged about 15% Thursday, and was on track for the biggest single-day advance since 2019 after posting earnings that topped estimates.

3 months ago - Benzinga